Pearson price target raised to 475 GBp from 450 GBp at Berenberg » 12:2701/1201/12/21
Berenberg analyst Sarah…
Berenberg analyst Sarah Simon raised the firm's price target on Pearson to 475 GBp from 450 GBp and keeps a Sell rating on the shares.
|Over a month ago|
Pearson price target raised to 750 GBp from 650 GBp at UBS » 12:4512/1712/17/20
UBS analyst Adam Berlin…
UBS analyst Adam Berlin raised the firm's price target on Pearson to 750 GBp from 650 GBp and keeps a Buy rating on the shares.
Fly Intel: Top five analyst downgrades » 09:5612/0912/09/20
ZM, CRWD, DOCU, OKTA, PANW, HFC, TOT, PSO, MRNA
Catch up on today's…
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Zoom Video (ZM), Crowdstrike (CRWD), Okta (OKTA) and DocuSign (DOCU) all downgraded to Neutral from Overweight, with Palo Alto Networks (PANW) downgraded to Underweight from Neutral at JPMorgan. 2. HollyFrontier (HFC) downgraded to Underweight from Equal Weight at Wells Fargo with analyst Roger Read saying he favors Delek US's (DK) option to buy into a smaller facility post-construction over HollyFrontier's project execution risks of constructing two separate facilities and ongoing capex requirements related to normal refining operations. 3. Total (TOT) downgraded to Hold from Buy at Berenberg with analyst Henry Tarr saying the correlation between the energy sector's relative performance and oil prices may not hold given dividend cuts and an intensifying ESG focus, but it suggests around 10% relative upside to the prior trend line at current oil prices. 4. Pearson (PSO) downgraded to Reduce from Hold at Kepler Cheuvreux with analyst Conor O'Shea noting that the stock is pricing in the potential positive impact from the company's appointment of a new CEO along with the 2021 recovery in Global Assessment and International activities. 5. Moderna (MRNA) downgraded to Hold from Buy at Needham with analyst Alan Carr saying while he thinks Moderna has made "significant progress" towards validation of its mRNA platform, particularly through the development of COVID-19 vaccine mRNA-1273, with the stock up 770% year-to-date he believes shares are fully valued. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
Pearson cut to Reduce at Kepler Cheuvreux after recent share price rally » 06:3012/0912/09/20
Kepler Cheuvreux analyst…
Kepler Cheuvreux analyst Conor O'Shea downgraded Pearson to Reduce from Hold with a higher price target of 625 GBp, up from 550 GBp. The analyst notes that the stock is pricing in the potential positive impact from the company's appointment of a new CEO along with the 2021 recovery in Global Assessment and International activities. O'Shea believes however that "there is no easy fix", and after the recent share price rally above his modeled price target, the risks are higher.
Pearson downgraded to Reduce from Hold at Kepler Cheuvreux » 05:1912/0912/09/20
Kepler Cheuvreux analyst…
Kepler Cheuvreux analyst Conor O'Shea downgraded Pearson to Reduce from Hold.
Pearson price target raised to 840 GBp from 800 GBp at JPMorgan » 12:5012/0812/08/20
JPMorgan analyst Daniel…
JPMorgan analyst Daniel Kerven raised the firm's price target on Pearson to 840 GBp from 800 GBp and keeps an Overweight rating on the shares.
Pearson announces Mike Howells as new Chief Strategy Officer » 10:1312/0212/02/20
Pearson announced that…
Pearson announced that Mike Howells will become its new Chief Strategy Officer. "Mike will further strengthen Pearson's global corporate and educational partnerships as the company aims to expand and enhance its direct-to-consumer offering. He will be based in London and will work with the executive team and Board to shape and execute the plan for the business, reporting to Andy Bird, Chief Executive," the company stated. Howells was previously HM General Consul in Los Angeles. Reference Link
Pearson upgraded to Buy from Neutral at BofA » 10:0111/3011/30/20
BofA upgraded Pearson to…
BofA upgraded Pearson to Buy from Neutral with a price target of 770 GBp, up from 460 GBp. The firm sees an underlying revenue inflection point nearing, driven by double-digit growth in online learning and a turnaround in courseware.
Pearson upgraded to Outperform from Neutral at Exane BNP Paribas » 06:1111/0611/06/20
Exane BNP Paribas analyst…
Exane BNP Paribas analyst Sami Kassab upgraded Pearson to Outperform from Neutral with a 700 GBp price target. The analyst believes that higher education courseware will turn around, with the company's Inclusive Access, Direct-to-Student distribution, and new products help the company win back share in the secondary market. Kassab adds that Pearson's legacy headwinds and regulatory risks are abating.
UBS upgrades Pearson to Buy on positive U.S. education view » 08:1210/2610/26/20
UBS analyst Adam Berlin…
UBS analyst Adam Berlin upgraded Pearson to Buy from Neutral with a price target of 650 GBp, up from 545 GBp. The analyst is "getting more positive" on U.S. higher education. Pearson's higher education businesses can add greater than GBP 100M of EBIT between 2025, Berlin tells investors in a research note.